Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nobue Tanaka
Erratum To: Evaluation of Add-On Therapy of Sitagliptin in Japanese Patients With Type 2 Diabetes Under Insulin Therapy
Diabetology International
Internal Medicine
Endocrinology
Metabolism
Diabetes
Collaborative Interaction as the Process of Task Completion
JALT CALL Journal
Linguistics
Computer Science Applications
Education
Language
Related publications
Add-On Treatment With Teneligliptin Ameliorates Glucose Fluctuations and Improves Glycemic Control Index in Japanese Patients With Type 2 Diabetes on Insulin Therapy
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients With Type 2 Diabetes: The EDIT Randomized Trial
PLoS ONE
Multidisciplinary
Is a Switch From Insulin Therapy to Liraglutide Possible in Japanese Type 2 Diabetes Mellitus Patients?
Journal of Clinical Medicine Research
Efficacy and Safety of Ipragliflozin Add‐on Therapy to Insulin in Japanese Patients With Type 1 Diabetes Mellitus: A Randomized, Double‐blind, Phase 3 Trial
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Exenatide Add-On to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients With Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Comparative Outcomes of Basal Insulin and Oral Anti-Diabetic Agent as an Add-On to Dual Therapy in Patients With Type 2 Diabetes Mellitus
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes Receiving Basal–Bolus Therapy
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-On to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes